Suppr超能文献

体外膜肺氧合治疗成人患者心肺功能衰竭

[Extracorporeal membrane oxygenation for treatment of cardiorespiratory function failure in adult patients].

作者信息

Luo Xin-jin, Wang Wei, Sun Han-song, Hu Sheng-shou, Long Cun, Xu Jian-ping, Song Yun-hu, Hei Fei-long

机构信息

Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2009 Oct 15;47(20):1563-5.

Abstract

OBJECTIVE

To explore the experience on venoarterial extracorporeal membrane oxygenation (ECMO) in adult patients with cardiac failure.

METHODS

From February 2005 to June 2008, 45 patients (male 34, female 11) undergoing cardiogenic shock required temporary ECMO support. Average age was (49.0 +/- 14.1) years. Average body weight was (67.0 +/- 12.8) kg. Coronary heart disease occupied in 21 cases, valve disease occupied in 8 cases, and cardiomyopathy occupied in 7 cases. All the patients could be divided into 3 groups: post-cardiotomy (group 1, n = 31), post-transplantation (group 2, n = 5), decompensate of chronic heart failure (group 3, n = 9). Fourteen patients need cardiac resuscitation before ECMO support. ECMO implantation was performed through the femoral vessels or axillary artery or through the right atrium and ascending aorta.

RESULTS

Average support duration of ECMO was (126.7 +/- 104.3) h. Twenty-seven patients could be successfully weaned from support (60.0%), additionally, 5 were bridged to heart transplantation. The in-hospital mortality was 42.2% (19/45). Twenty-six patients (57.8%) could be successfully discharged. The discharge rate was 58.1% in group 1, 4/5 in group 2 and was 4/9 in group 3. Twelve patients were re-operated for hemostasis. Three patients need femoral arterial thrombectomy because of ischemia of lower extremity. Additional intra-aortic balloon pumps were used in 11 patients, with 6 patients successfully discharged. The mortality rate for patients with acute renal failure treated by continuous renal replacement therapy under ECMO support was obviously high (7/9). The dominant mode of death was multisystem organ failure (9/19).

CONCLUSION

Early indication, control of complications, and paying attention to the treatment after ECMO support could improve our results with increasing experience.

摘要

目的

探讨成人心力衰竭患者静脉 - 动脉体外膜肺氧合(ECMO)治疗的经验。

方法

2005年2月至2008年6月,45例(男34例,女11例)心源性休克患者需要临时ECMO支持。平均年龄为(49.0±14.1)岁。平均体重为(67.0±12.8)kg。冠心病21例,瓣膜病8例,心肌病7例。所有患者可分为3组:心脏术后(第1组,n = 31),移植术后(第2组,n = 5),慢性心力衰竭失代偿期(第3组,n = 9)。14例患者在ECMO支持前需要心脏复苏。通过股血管或腋动脉或经右心房和升主动脉进行ECMO植入。

结果

ECMO平均支持时间为(126.7±104.3)小时。27例患者成功撤机(60.0%),另外,5例过渡到心脏移植。住院死亡率为42.2%(19/45)。26例患者(57.8%)成功出院。第1组出院率为58.1%,第2组为4/5,第3组为4/9。12例患者再次手术止血。3例患者因下肢缺血行股动脉血栓切除术。11例患者使用了主动脉内球囊反搏,6例患者成功出院。ECMO支持下接受持续肾脏替代治疗的急性肾衰竭患者死亡率明显较高(7/9)。主要死亡方式为多系统器官衰竭(9/19)。

结论

随着经验的增加,早期适应证、并发症的控制以及重视ECMO支持后的治疗可改善治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验